We are live on
!
Find out more
AAP
Aristotle Atlantic Partners Portfolio holdings
AUM
$2.14B
1-Year Est. Return
37.01%
This Fund
S&P 500
This Quarter
Est. Return
-12.54%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$655M
AUM Growth
-$128M
(-16%)
Cap. Flow
-$7.82M
Cap. Flow
% of AUM
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
45.75%
Holding
102
New
4
Increased
46
Reduced
19
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$7.1M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$1.46M |
| 3 |
Fidelity National Information Services
FIS
|
+$1.14M |
| 4 |
Apple
AAPL
|
+$1.08M |
| 5 |
Phillips 66
PSX
|
+$857K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.19M |
| 2 |
AYX
Alteryx Inc
AYX
|
+$5.65M |
| 3 |
Merck
MRK
|
+$3.71M |
| 4 |
Bio-Techne
TECH
|
+$2.1M |
| 5 |
Cigna
CI
|
+$1.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.71% |
| 2 | Technology | 25.24% |
| 3 | Industrials | 11.67% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Financials | 9.15% |
Similar funds
SC
EF
NAAA
GA
GHA
BCM
MA
GS
Aristotle Atlantic Partners's Q1 2020 Portfolio in Review
As of Q1 2020, Aristotle Atlantic Partners held 102 positions worth $655M, down 16% from $783M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Aristotle Atlantic Partners's Q1 2020 filing shows 4 new, 46 increased, 19 reduced and 10 closed positions. Its largest new stake was DexCom: 114,168 shares worth $7.69M. The largest sale was NVIDIA, an estimated $7.19M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
- Aristotle Atlantic Partners's largest Q1 2020 buy was DexCom: 114,168 shares worth $7.69M.
- Aristotle Atlantic Partners added most to Fidelity National Information Services in Q1 2020, an estimated $1.14M increase.
- Aristotle Atlantic Partners's biggest Q1 2020 reduction was NVIDIA, cutting an estimated $7.19M.
- Aristotle Atlantic Partners fully exited Supernus Pharmaceuticals in Q1 2020, selling an estimated $993K.
- Aristotle Atlantic Partners's ten largest holdings make up 46% of its $655M portfolio in Q1 2020.
- Aristotle Atlantic Partners opened 4 new positions and closed 10 in Q1 2020.
- Aristotle Atlantic Partners's portfolio value fell 16% quarter-over-quarter to $655M.
Based on Aristotle Atlantic Partners's 13F filing for Q1 2020, filed 14 May 2020.